Led by a team with experience in translational neuroscience, clinical development strategy, and advancing differentiated therapeutic programs.
Neuritek's team dedicates passion, experience
and knowledge to treatment development in PTSD.
Leadership Team
William E. Hapworth M.D.
, Founder
Founder of Neuritek Therapeutics, directing the scientific strategy behind its PTSD-focused therapeutic program. His work centers on advancing mechanism-driven approaches informed by translational and clinical insights.
He has played a key role in shaping the direction of Neuritek’s lead program as the company explores pathways to accelerate development. Full bio →
Chirag B. Raval, Ph.D, Chief Medical Officer
Focused on translational strategy and development of mechanism-based therapeutics. Contributor to the positioning and advancement of Neuritek’s lead program.
Interested in bridging scientific insight with real-world impact in neuropsychiatric disorders.. Full bio →
Board of Directors
Allan Bradley , Chairman and CEO
Mr. Bradley has over 16 years of C level experience. He is a M&A, regulatory, strategic, capital and capital markets expert. Allan has managed international finance and operations teams and sits on the board of directors for two technology companies and a public oil and gas corporation. Full bio →
Neuritek’s vision is to bring next-generation psychiatric therapies to market for people suffering from psychiatric disorders, focusing initially on PTSD.
Neuritek Therapeutics is a biopharmaceutical company committed to developing revolutionary treatments with the potential to transform the lives of patients and families suffering from psychiatric disorders.
Built on years of research and clinical care of patients with PTSD, our goal is to develop the first mechanism-based treatment for PTSD. We do this through rigorous basic and clinical science, innovative research methodologies, and highly efficient clinical trial operations.
Novel treatment development for PTSD has been declared a priority by the Institute of Medicine, the United States Department of Defense, and the United States Department of Veterans Affairs.